These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

192 related items for PubMed ID: 4374230

  • 1. Immunity to tumours of the murine leukaemia-sarcoma virus complex.
    Owen JJ, Seeger RC.
    Br J Cancer Suppl; 1973 Aug; 1():26-34. PubMed ID: 4374230
    [Abstract] [Full Text] [Related]

  • 2. Anti-tumour cytotoxic effects mediated by minor and major cell populations of lymph nodes.
    Seeger RC, Owen JJ.
    Nature; 1974 Nov 29; 252(5482):420-1. PubMed ID: 4547827
    [No Abstract] [Full Text] [Related]

  • 3. Further evidence for the involvement of thymus-processed lymphocytes in syngeneic tumor cell cytolysis.
    Plata F, Gomard E, Leclerc JC, Levy JP.
    J Immunol; 1973 Sep 29; 111(3):667-71. PubMed ID: 4542607
    [No Abstract] [Full Text] [Related]

  • 4. Incorporation of 125-I-iododeoxyuridine into target cells as an assay for cell immunity.
    Fish F, Yaakubovicz M, Witz IP.
    J Natl Cancer Inst; 1974 Dec 29; 53(6):1743-7. PubMed ID: 4436870
    [No Abstract] [Full Text] [Related]

  • 5. Cell-mediated immunity to Friend virus-induced leukemia.
    Ting CC, Shiu G, Rodrigues D, Herberman RB.
    Cancer Res; 1974 Jul 29; 34(7):1684-7. PubMed ID: 4134674
    [No Abstract] [Full Text] [Related]

  • 6. Studies of the mechanisms for the induction of in vivo tumor immunity. III. Recruitment of host helper cells by donor T cells in adoptive transfer of cell-mediated immunity.
    Ting CC, Rodrigues D, Igarashi T.
    J Immunol; 1979 Apr 29; 122(4):1510-8. PubMed ID: 221575
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. In vitro studies of cell-mediated immunity in an acute viral infection.
    McFarland HF.
    J Immunol; 1974 Jul 29; 113(1):173-80. PubMed ID: 4598885
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Enhancement of normal lymphocyte cytotoxicity by sera with high antibody titers against H-2 or virus-associated antigens.
    Harada M, Pearson G, Pettigrew H, Redmon L, Orr T.
    Cancer Res; 1973 Nov 29; 33(11):2886-93. PubMed ID: 4583975
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Immunity to murine sarcoma virus-inducted tumors. II. Suppression of T cell-mediated immunity by cells from progressor animals.
    Gorczynski RM.
    J Immunol; 1974 May 29; 112(5):1826-38. PubMed ID: 4361978
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Increased tumorigenesis of murine sarcoma virus (Moloney) by coinfection with Rauscher virus or by treatment with antilymphocyte serum.
    Hook WA, Chirigos MA, Chan SP.
    Cancer Res; 1969 May 29; 29(5):1008-12. PubMed ID: 5781092
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.